KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $214.0 million.

  • Quest Diagnostics' Net Income towards Common Stockholders rose 7.54% to $214.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $844.0 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $867.0 million for FY2024, which is 2.36% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Net Income towards Common Stockholders is $214.0 million, which was down 14.40% from $250.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Net Income towards Common Stockholders high stood at $599.0 million for Q2 2021, and its period low was $76.0 million during Q4 2022.
  • Over the past 3 years, Quest Diagnostics' median Net Income towards Common Stockholders value was $196.0 million (recorded in 2024), while the average stood at $194.5 million.
  • As far as peak fluctuations go, Quest Diagnostics' Net Income towards Common Stockholders surged by 830.43% in 2021, and later crashed by 78.22% in 2022.
  • Quest Diagnostics' Net Income towards Common Stockholders (Quarterly) stood at $349.0 million in 2021, then slumped by 78.22% to $76.0 million in 2022, then soared by 113.16% to $162.0 million in 2023, then grew by 20.99% to $196.0 million in 2024, then grew by 7.54% to $214.0 million in 2025.
  • Its Net Income towards Common Stockholders was $214.0 million in Q3 2025, compared to $250.0 million in Q2 2025 and $184.0 million in Q1 2025.